IP Library › Assignment 057801/0484
Patent Assignment
Reel/Frame 057801/0484

Release of Security Interest

Recorded: 2021-10-15 Pages: 6
Assignor
CIT BANK, N.A.
Executed: 2021-10-12
Assignee
RVL PHARMACEUTICALS, INC.
400 CROSSING BOULEVARD, BRIDGEWATER, NEW JERSEY, 08807
Covered Properties (8)
Compositions and Methods for Treating Blepharoptosis
Application: 62/843,819 →
Compositions and Methods for Treating Blepharoptosis
Application: 62/844,069 →
Oxymetazoline Compositions
Application: 16/715,998 →
Publication: US 2020/0353083
Compositions and Methods for Treating Ocular Disorders
Application: 16/716,014 →
Oxymetazoline Compositions
Application: 17/064,915 →
Publication: US 2021/0023222
Compositions and Methods for Treating Ocular Disorders
Application: 17/063,416 →
Publication: US 2021/0015795
Oxymetazoline Compositions
Application: 17/154,676 →
Publication: US 2021/0137889
Compositions and Methods for Treating Ocular Disorders
Application: 17/194,559 →
Publication: US 2021/0212992
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 27, 2020
From: DEVRIES, TINA; JACOBS, DAVID
To: REVITALID, INC.
Reel/Frame 051955/0105 →
Change of Name May 5, 2020
From: REVITALID, INC.
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 052578/0827 →
Security Interest May 22, 2020
From: RVL PHARMACEUTICALS, INC.
To: CIT BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 052734/0192 →
Assignment of Assignor's Interest Oct 7, 2020
From: DEVRIES, TINA; JACOBS, DAVID
To: REVITALID, INC.
Reel/Frame 053997/0850 →
Change of Name Oct 7, 2020
From: REVITALID, INC.
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 054001/0419 →
Change of Name Oct 7, 2020
From: REVITALID, INC.
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 054005/0623 →
Assignment of Assignor's Interest Oct 7, 2020
From: DEVRIES, TINA; JACOBS, DAVID
To: REVITALID, INC.
Reel/Frame 054000/0603 →
Security Interest Jan 25, 2021
From: RVL PHARMACEUTICALS, INC.
To: CIT BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 055015/0762 →
Security Interest Jun 30, 2021
From: RVL PHARMACEUTICALS, INC.
To: CIT BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 056724/0588 →
Assignment of Assignor's Interest Jul 28, 2021
From: DEVRIES, TINA; JACOBS, DAVID
To: REVITALID, INC.
Reel/Frame 057004/0526 →
Change of Name Jul 28, 2021
From: REVITALID, INC.
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 057012/0735 →
Change of Name Sep 1, 2021
From: REVITALID, INC.
To: RVL PHARMCEUTICALS, INC.
Reel/Frame 057393/0665 →
Assignment of Assignor's Interest Sep 1, 2021
From: DEVRIES, TINA; JACOBS, DAVID
To: REVITALID, INC.
Reel/Frame 057357/0850 →
Notice of Grant of Security Interest in Patents Oct 12, 2021
From: RVL PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES IV ACQUISITION LP, AS ADMINISTRATIVE AGENT
Reel/Frame 057787/0507 →
Release of Patent Security Agreements Oct 15, 2021
From: CIT BANK, N.A., AS COLLATERAL AGENT
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 057819/0436 →
Corrective Assignment to Correct the Assignee's Name Previously Recorded on Reel 053739 Frame 0665. Assignor(S) Hereby Confirms the Change of Name. Jul 7, 2022
From: REVITALID, INC.
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 060613/0512 →
Notice of Grant of Security Interest in Patents Nov 27, 2023
From: RVL PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES IV ACQUISITION LP, AS ADMINISTRATIVE AGENT
Reel/Frame 065676/0617 →
Termination and Release of Security Interest in Patents Recorded at Reel 057787, Frame 0507 Nov 27, 2023
From: ATHYRIUM OPPORTUNITIES IV ACQUISITION LP, AS ADMINISTRATIVE AGENT
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 065676/0610 →